Pages that link to "Q51213361"

The following pages link to Long-term follow-up of children prenatally exposed to ritodrine (Q51213361):

Displaying 14 items.

• Absence of neurotoxicity with medicinal grade terbutaline in the rat model. (Q30574999) (← links)
• A risk-benefit assessment of therapies for premature labour (Q33703346) (← links)
• Prenatal exposure to drugs: effects on brain development and implications for policy and education (Q34960692) (← links)
• Terbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor (Q36381363) (← links)
• Pleiotropic effects of neurotransmission during development: modulators of modularity (Q37224539) (← links)
• Problems in studying functional teratogenicity in man. (Q39523428) (← links)
• In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children (Q40341694) (← links)
• Association between Beta-Sympathomimetic Tocolysis and Risk of Autistic Spectrum Disorders, Behavioural and Developmental Outcome in Toddlers (Q43281049) (← links)
• Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver (Q44237521) (← links)
• Terbutaline Is a Developmental Neurotoxicant: Effects on Neuroproteins and Morphology in Cerebellum, Hippocampus, and Somatosensory Cortex (Q44650601) (← links)
• beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort (Q48321102) (← links)
• Child development after maternal tocolysis with beta-sympathomimetic drugs (Q51969820) (← links)
• The neurology of learning and behavioural problems in pre-adolescent children (Q52103740) (← links)
• Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study (Q58775160) (← links)